LSM14B

LSM14B is an oocyte-specific RNA-binding protein with an N-terminal Lsm domain that functions as a ribonucleoprotein interaction hub controlling the storage, stability, and translation of maternal mRNAs throughout oocyte development and early embryogenesis (PMID:37083226, PMID:37578641). It partitions into membraneless compartments — P-body-like granules, stress-granule-like assemblies, and mitochondria-associated ribonucleoprotein domains (MARDO) — and its loss disrupts these granules, impairing maternal mRNA accumulation in non-growing oocytes and translational control in fully grown oocytes (PMID:22614839, PMID:37578641). LSM14B exerts bidirectional translational control: within a DDX6–LSM14B–CPEB1 complex it represses cyclin B1 translation through the cyclin B1 3'UTR to maintain prophase arrest (PMID:39567493), while through its N-terminal RNA recognition motifs it binds Musashi1 to activate translation of target mRNAs (PMID:40211036). Through these activities LSM14B governs the expression and localization of core P-body components including DDX6, LSM14A, DCP1A, and 4E-T (PMID:37481122), and is required for oocyte meiotic maturation, with its loss causing meiotic arrest, spindle and chromosome defects, and female-specific infertility (PMID:28458300, PMID:37083226, PMID:37578641). In somatic epithelial cells LSM14B acts as a negative regulator of P-body assembly [PMID:bio_10.1101_2025.10.30.685488].

1. 2004 Low

   Established LSM14B's existence as a distinct Lsm-domain protein, raising the possibility of a nucleic-acid-binding and cell-cycle-regulatory role before any experiment was done.

   Evidence Integrative bioinformatics and computational domain analysis

   PMID:15225602

   Open questions at the time

   • Computational prediction only with no experimental validation of binding or function
   • No localization or partner data
   • G2/M role inferred from yeast partners, not tested
2. 2010 Medium

   Placed LSM14B inside a defined oocyte mRNP, answering whether it associates with the translational repression machinery by showing it co-purifies with CPEB and Xp54/DDX6.

   Evidence Co-immunoprecipitation of epitope-tagged Pat1 from Xenopus oocyte extracts identifying CPEB, Xp54, eIF4E1b, ePAB partners

   PMID:20826699

   Open questions at the time

   • Association does not establish direct binding versus indirect complex membership
   • Functional consequence of the interactions not tested
   • Single organism (Xenopus)
3. 2012 Medium

   Defined LSM14B's subcellular behavior, showing it localizes to P-bodies and can nucleate large mixed P-body/stress-granule assemblies.

   Evidence Fluorescence microscopy and marker immunostaining of expressed RAP55B in human cultured cells

   PMID:22614839

   Open questions at the time

   • Based on overexpression, which may force granule formation
   • Endogenous localization not assessed
   • No mechanism for granule nucleation
4. 2015 Medium

   Distinguished LSM14B functionally from its paralog by showing it associates with polysomes and translatable mRNAs, pointing toward a translational activation rather than repression role.

   Evidence Co-IP, polysome fractionation, and RNA binding assays in Xenopus oocytes

   PMID:26455898

   Open questions at the time

   • Direct activation of specific mRNAs not demonstrated
   • Apparent contradiction with later repression role not resolved here
   • Single lab, Xenopus only
5. 2017 Medium

   Provided the first loss-of-function evidence that LSM14B is required for meiotic maturation, linking it to cell-cycle progression via candidate targets Cyclin B1 and Cdc20.

   Evidence LSM14B knockdown in mouse oocytes with spindle/chromosome immunofluorescence and mRNA level analysis

   PMID:28458300

   Open questions at the time

   • Targets identified by correlation, not direct binding or reporter assay
   • Mechanism of mRNA regulation unresolved
   • Knockdown rather than genetic null
6. 2023 High

   Established LSM14B as an oocyte-specific RNA-binding interaction hub whose genetic loss causes female infertility, defining its physiological requirement across oogenesis and early embryogenesis.

   Evidence mRNA-interactome capture, Lsm14b knockout mouse, translation reporters, and proteomic interaction mapping

   PMID:37083226

   Open questions at the time

   • Full identity of the bound mRNA and protein interactome not exhaustively resolved
   • Direct versus indirect translational effects not separated for all targets
7. 2023 High

   Connected LSM14B to specific membraneless compartments (P-body-like granules and MARDO) and tied granule integrity to maternal mRNA stability and timely MPF activation.

   Evidence Conditional knockout mouse, scRNA-seq, bulk RNA-seq, immunostaining of granule components, and WEE1/2 inhibitor rescue

   PMID:37578641

   Open questions at the time

   • Molecular basis for LSM14B-dependent granule assembly not defined
   • How granule dissolution links mechanistically to translation onset unresolved
8. 2023 High

   Showed LSM14B controls the expression and localization of core P-body machinery, including DDX6, LSM14A, DCP1A, and 4E-T, placing it upstream of P-body composition in oocytes.

   Evidence Lsm14b knockout mouse, global transcriptome analysis, and immunostaining/localization analysis of P-body components

   PMID:37481122

   Open questions at the time

   • Whether effects on DDX6 nuclear accumulation are direct or secondary unclear
   • Mechanism restraining aberrant transcriptional activation not defined
9. 2024 High

   Resolved a direct mechanism of translational repression, showing a DDX6–LSM14B–CPEB1 complex silences cyclin B1 via its 3'UTR to hold oocytes in prophase arrest.

   Evidence Trim-Away depletion of each component, cyclin B1 translational reporter, and 3'UTR RNA interaction assay in mouse oocytes

   PMID:39567493

   Open questions at the time

   • Stoichiometry and assembly order of the tripartite complex not defined
   • Whether LSM14B binds the 3'UTR directly or through CPEB1 not separated
10. 2024 Medium

    Demonstrated LSM14B is a physiological mediator of oocyte quality by showing its restoration rescues translation, mitochondrial, and meiotic defects in metabolically stressed oocytes.

    Evidence siRNA knockdown and Lsm14b mRNA rescue injection in mouse oocytes with RNA-seq and mitochondrial/meiotic assays

    PMID:38552928

    Open questions at the time

    • Direct LSM14B targets driving mitochondrial phenotype not identified
    • Link between mRNA storage defects and mitochondrial dysfunction mechanistically incomplete
11. 2025 High

    Defined the molecular basis of LSM14B-mediated translational activation, mapping a Musashi1 interaction to its N-terminal RRMs and showing it is required for Musashi1-dependent activation of target mRNAs.

    Evidence Co-IP, domain-mapping mutagenesis, translational reporters in Xenopus oocytes, and validation on mammalian Prop1 mRNA

    PMID:40211036

    Open questions at the time

    • How LSM14B switches between repressive and activating complexes not resolved
    • Full set of Musashi1/LSM14B co-activated mRNAs unknown
12. 2025 Medium

    Extended LSM14B function to somatic cells, showing it negatively regulates P-body formation and that its glucocorticoid-driven loss promotes P-body accumulation and AU-rich mRNA sequestration.

    Evidence Genetic invalidation and rescue, FDA-approved drug screen, P-body quantification microscopy, and translational reporters (preprint)

    PMID:bio_10.1101_2025.10.30.685488

    Open questions at the time

    • Preprint, not yet peer-reviewed
    • Mechanism by which LSM14B restrains P-body assembly in somatic cells undefined
    • Direct AU-rich mRNA targets not enumerated

• How LSM14B is partitioned between repressive (DDX6/CPEB1) and activating (Musashi1) complexes, and what determines its switch between promoting and restraining granule assembly across oocyte and somatic contexts, remains unresolved.
• No structural model of LSM14B complexes
• Regulatory signals controlling complex choice unknown
• Direct RNA-binding specificity of the Lsm domain not mapped